Amino Acid PET-based Response Assessment in IDH-mutant Gliomas (APPEAR) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Amino Acid PET-based Response Assessment in IDH-mutant Gliomas (APPEAR) — Stella

Recruiting

Back to IDH-mutant Glioma (Oligodendroglioma, Astrocytoma) trials

Trial locations(2 sites)

Austria

Medical University of Vienna, Vienna

Germany

LMU Hospital, Munich, Bavaria

Key details

Sponsor

LMU Klinikum

Collaborators

Servier Affaires Médicales, Servier Deutschland GmbH

Enrollment target

~100 participants

Started

July 2025

Primary completion

July 2030

Age range

18 Years and older

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov